Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The glucose tolerance test (GTT) market has seen significant trends and developments in recent years, reflecting changes in healthcare practices, advancements in diagnostic technologies, and evolving patient needs. One notable trend is the increasing prevalence of diabetes and prediabetes worldwide, driven by factors such as sedentary lifestyles, unhealthy diets, and aging populations. As the incidence of diabetes continues to rise, there is a growing demand for accurate and reliable diagnostic tests such as the GTT to identify individuals at risk and facilitate early intervention and management. This trend is driving market growth in the GTT segment as healthcare providers seek to meet the growing demand for diabetes screening and diagnosis.
Furthermore, there is a growing emphasis on personalized medicine and precision diagnostics in the management of diabetes and metabolic disorders, driving the adoption of advanced GTT techniques and protocols tailored to individual patient needs. Traditional GTT methods involve administering a standardized glucose load and measuring blood glucose levels at specific time intervals to assess glucose tolerance and insulin sensitivity. However, there is increasing interest in alternative GTT protocols such as the oral glucose tolerance test (OGTT), intravenous glucose tolerance test (IVGTT), and mixed meal tolerance test (MMTT), which offer insights into different aspects of glucose metabolism and insulin secretion. These advanced GTT techniques enable more comprehensive assessment of metabolic function and facilitate targeted interventions to optimize glycemic control and prevent diabetes-related complications.
Moreover, technological advancements in glucose monitoring devices and continuous glucose monitoring (CGM) systems are driving innovation in the GTT market, enabling real-time monitoring of glucose levels and dynamic assessment of glucose tolerance profiles. CGM systems provide continuous glucose data over extended periods, allowing for detailed analysis of glucose variability, postprandial excursions, and nocturnal glycemia patterns. Integration of CGM data with GTT results offers a holistic view of glucose metabolism and insulin dynamics, guiding personalized treatment strategies and lifestyle interventions for individuals with impaired glucose tolerance and diabetes. Additionally, advancements in wearable glucose sensors and smartphone-based glucose monitoring apps enhance patient convenience and engagement in self-management of diabetes.
Additionally, there is a trend towards the development of point-of-care (POC) GTT devices and rapid diagnostic tests for convenient and timely screening of diabetes and prediabetes in primary care settings. POC GTT devices offer advantages such as rapid results, minimal sample volume requirements, and ease of use, making them suitable for use in community health centers, pharmacies, and mobile clinics. These POC GTT devices enable early detection of glucose abnormalities, facilitate prompt referral to specialized care providers, and empower patients to take proactive steps towards lifestyle modifications and disease prevention. Furthermore, integration of POC GTT devices with electronic health record (EHR) systems enables seamless documentation and tracking of screening results, supporting population health management initiatives and quality improvement efforts in diabetes care.
Furthermore, the GTT market is witnessing expansion opportunities in emerging markets and developing regions, driven by rising awareness of diabetes, increasing healthcare infrastructure, and growing investment in preventive healthcare initiatives. Governments, healthcare providers, and industry stakeholders are collaborating to improve access to diagnostic services, diabetes education, and lifestyle interventions for individuals at risk of diabetes and prediabetes. Market players are expanding their presence in emerging markets, introducing affordable GTT solutions, and implementing community-based screening programs to address unmet needs and reduce the burden of diabetes on healthcare systems.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Market Opportunities | The rise in demand for glucose tolerance test market. |
Glucose Tolerance Test Market Highlights:
Glucose Tolerance Test Market Overview
The Glucose Tolerance Test Market Size was valued at USD 26.90 Billion in 2023. The Global Glucose Tolerance Test industry is projected to grow from USD 29.11 Billion in 2024 to USD 51.10 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.45% during the forecast period (2024 - 2032). For measuring the capacity of engrossing glucose after consumption of the given amount of sugar to the patient, a glucose tolerance test is used. It tells the level of sugar that can be tolerated by a person suffering from diabetes. For identifying type 1 and type 2 diabetes, specialists use values of hemoglobin A1c and fasting blood sugar levels. The glucose tolerance test market is also used for testing pre-diabetes in potential diabetic patients. Initially, to diagnose gestational diabetes, glucose tolerance tests are used on patients and hence lead to the growth of the market in the global market.
COVID 19 Analysis
The global pandemic of COVID 19 has adversely affected the normal working of people. With the growing outbreak of COVID 19, now one has to deal with financial crises along with health concerns. This situation has pushed the economies towards forced recession. Owing to the lockdown situation the supply chain network of the market has been distributed which resulted in a steep downfall of sales revenue.
However, it is expected that the glucose tolerance test market will recover from this pandemic situation by the end of the second quarter of the coming year.
Glucose Tolerance Test Market Trends
Drivers
The demand for glucose tolerance test market is increasing rapidly in the global market owing to an increase in diabetic patients worldwide. The increasing investment in the research funding for diagnosis and treatment, related to awareness and screening accelerates the pace of growth in the in the global market. The changing lifestyle because of more urbanization is another contributing factor for boosting the growth in the global market.
Opportunities
The rise in demand for glucose tolerance test market. Various growth opportunities can be seen in the market during the forecasted period as governments of various emerging countries are spending a huge amount as the investment market for providing testing facility in every region in the global market. The government of various emerging countries is also encouraging and supporting research in the fields of market for applying the theoretical knowledge in practical experience.
Restraints
The glucose tolerance test market is increasing at a constant rate but some factors restrict the growth of the market. The restrictions regarding the reimbursement and insurance policies of various emerging countries hinder the growth in the global market. The high cost required for treatment and diagnosis of diabetes is another factor that hinders the growth in the global market.
Value Chain Analysis
The glucose tolerance test market is increasing tremendously in the global market. The market has various benefits and hence adds value to society. The market helps in monitoring the blood sugar level in the dietetic patients and tells about the proportion of sugar that a diabetic patient can tolerate and intake.
Glucose Tolerance Test Market Segment Insights
The glucose tolerance test market in the global market has been divided based on the product, indication, and end-users.
Glucose Tolerance Test Market Product Insights
The global market has been divided based on the product into smart sensors, blood glucose testing kits, and many others. The blood glucose testing kit is further sub-divided into test strips, meters, lancet, and many others. The largest market share in the product division is held by the blood glucose testing kit owing to a sudden increase in diabetes patients.
Glucose Tolerance Test Market Indication Insights
The global market has been divided based on the indication into reactive hypoglycemia, insulin resistance, gestational diabetes, diabetes, and many others. The largest market share in the indication division is held by the diabetes dividend owing to the rise in patients suffering from diabetes due to unhealthy lifestyles.
Glucose Tolerance Test Market End-Users Insights
The global market has been divided based on the end-users into homes, hospitals, dispensaries, diagnostic clinics, and many others. The largest market share in the end-users division is held by the diagnostic clinics' division as it is expected to grow at a high CAGR of 34.5% during the forecasted period.
Glucose Tolerance Test Market Regional Insights
The glucose tolerance test market in the global market has been divided based on the region into Asia-Pacific region, European region, North American region, and the Middle East and African region. The largest market share in the global market is held by the North American region and hence it dominates in the global market. This is because of the increase in expenditure on healthcare, increase in cases of diabetes mellitus (DM), and increase in advancement of technology.
The second-largest market share in the global market is held by the European region. This region is further sub-divided into the Eastern European region and Western European region. Countries like U.K., Spain, Italy, France, and Germany come under the Western European region. Owing to an increase in presence of the geriatric population, healthcare infrastructure, and research, and development leads to the growth of the market.
The third-largest market share in the glucose tolerance test market in the global market is held by the Asia-Pacific region as this is the fastest-growing region. This region has various growth opportunities during the forecasted period owing to the presence of highly populated countries in this region. Improvement in the healthcare sector is another contributing factor.
A restricted growth has been seen in the Middle East and African region owing to poor and slow growth in countries of the African region.
Competitive Landscape
The most prominent major key players are mentioned below:
- Panasonic
- Dexcom, Inc.
- Abbott Laboratories
- Hoffman-La Roche Ltd.
- LifeScan, Inc.
- Sanofi
- Medtronic PLC
These major key players in the market use various strategies and policies to sustain their market position in the global market by forming a partnership, establishing collaboration, setting up new joint ventures, developing a new product, innovation in existing product, developing new production process to minimize the cost, and many other strategies to penetrate in the untapped market for increasing their customer base in the global market.
Recent Developments
- In January 2016, the completion of Panasonic Healthcare’s has been announced for the acquisition of Bayer AG’s Diabetes Care Business by the Panasonic Healthcare Holdings, Co., Ltd.
- In February 2016, a new launch of new testing protocols has been announced by the Salimetrics for helping in the investigators’ study regarding childhood and adult obesity such as heart disease, biological pathways of insulin, metabolic syndrome, and type II diabetes for improving the efficiency in working.
- In September 2016, the approval for the FreeStyle Libre Pro System has been received from the US Food and Drug Administration (FDA) by Abbott.
- In January 2017, the chrome blood glucose monitoring kit has been launched by One Drop for providing a better way for an iOS-based option for people suffering from diabetes. This will help in tracking food intake, glucose level, and activities through this app
Report Overview
This glucose tolerance test market research report consists of the following elements:
- Market Overview
- COVID 19 Analysis
- Market Dynamics
- Value Chain Analysis
- Market Segmentation
- Regional Analysis
- Competitive Landscape
- Recent Developments
This glucose tolerance test market research report contains various factors that drive the growth of the tolerance test market along with the factors that restrict the growth of the market. The growth opportunities available in the market during the forecasted period are mention. The impact of the global pandemic of COVID 19 on the sales revenue of the market is also mentioned. The future growth rate of the market is estimated and mentioned.
Users
Pharmaceutical companies, potential investors, market research, and consulting service providers, research and development (R&D) companies, medical devices manufacturer, and many others.
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
